Top 50 Medical Startup Investors in China

Investor	Medical China investments
Sequoia Capital China	30
Med-Fine Capital	24
BioVenture	22
Qiming Venture Partners	21
Legend Capital	21
Frees Fund	18
Puhua Capital	17
Cowin Venture	16
Marathon Venture Partners	15
Northern Light Venture Capital	14
Legend Star	14
IDG Capital	13
Highlight Capital	12
BioTrack Capital	12
Lilly Asia Ventures	12
Prox Ventures	11
Dalton Venture	11
Goldport Capital	10
Share Capital	10
Cenova	10
Cowin Capital	10
Gaorong Capital	9
Hillhouse Investment	9
Sunland Fund	9
CDH Investments	9
Trustbridge Partners	9
CD Capital	8
Haibang Capital	8
ZSVC	8
Sunz Fund	8
Co-Stone Venture Capital	8
Taiyu Investment	8
Sherpa Healthcare Partners	8
Huagai Capital	7
LYFE Capital	7
Tiantu Capital	7
Shanghai Biomedical Industrial Equity Investment Fund	7
Oriza Seed Capital (Oriza Yuandian)	7
Shunwei Capital	7
OrbiMed	7
Longpan Investment	7
Volcanics Venture	7
Oriental Fortune Capital	7
Long Hill Capital	7
Kaitai Capital	7
Oriza Holdings	7
Ping An Ventures	7
SBCVC	7
DT Capital Partners	7
Sinovation Ventures	7

We help founders build enduring companies.

Investment focus

Biotechnology, Health Care, Artificial Intelligence
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
UTA AI — Wanderboat is a travel + outing AI companion to find and sort the best point of interest with videos, images, and insights. From signature dishes to photo spots, you can ask questions freely in-chat, in-document, or on-map for personalized experiences.
Sanshou Technology — Sanshou Technology focuses on researching and developing smart motorcycles.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
Phrontline Biopharma — Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

LTZ Therapeutics — LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Zhongyi Rehabilitation — Zhongyi Rehabilitation is a provider of rehabilitation products and services that focuses on the operation of chain rehabilitation centers to provide patients with one-stop professional rehabilitation needs and solutions.
Chenzhang Biotechnology — Chenzhang Bio is a biotechnology developer specializing in stem cell storage and treatment technology. focusing on stem cell storage and treatment technologies, company's research and commercialization, enhancing its R&D team and promoting clinical application of stem cell treatment technology

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

DK MedTech — Dingke Medical is a medical device tech firm specializing in the R&D and production of vascular interventional medical treatment products.
Ensurge Medical — Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.
Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Biotechnology, Medical
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

Polycent — Polycent, a technology company with expertise in power technology, industrial control, data intelligence, and FPGA, develops digital power solutions using advanced electrical, sensing, and algorithm technologies, accelerating industrialization and high-quality power system development.
Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
Hangkai Microelectronics — Hangkai MicroTech focuses on the research, development, and manufacturing of Mems technology and products, with an emphasis on the demand for domestic sensor substitutes.

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, United Kingdom, United States

Portfolio highlights

Glbizzia — Glbizzia is a company specializing in genetic testing, data utilization, and biological breeding platforms, focusing on high-throughput omics big data analysis, intelligent omics experiments, and scientific research consulting.
Garen Semiconductor — Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide).
ICleague Technology — ICleague Technology to satisfy situations requiring high processing power, high bandwidth, and low power consumption.

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Investment focus

Health Care, Biotechnology, Medical
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Xingmu — Xingmu creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses.
ZWI Therapeutics, Inc. — ZWI Therapeutics biotech therapeutics polymer
Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
weshare — Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide throughcontinuous exploration and technologies.

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Investment focus

Health Care, Medical, Biotechnology
Series A, Angel, Seed
China, United States, France

Portfolio highlights

Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Arnatar Therapeutics — Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Carbon Energy Technology — Carbon Energy Technology develops technology for carbon utilization and its commercialization.

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Sentient — Community-built open AGI
Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Shifan Microelectronics — Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.

BioTrack Capital is a China-based investment firm.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Singapore

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Shenluo Medical — Shenluo Medical manufactures functional neural implantable medical devices.
Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Targeting One — Targeting One is an in-vitro diagnostic product developer.
Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
China, United States, United Kingdom

Portfolio highlights

Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Angel
China

Portfolio highlights

Pharmolix — Pharmolix is a biomedical company that focuses on the R&D and application of large models in the vertical industry of biomedicine.
Kangyuan Medical — Kangyuan Medical is committed to developing, and manufacturing a new generation of precise and effective blood purification adsorption materials.
Jichen Biotechnology — Jichen Biotechnology designs, manufactures, supplies, and maintains automation and information equipment systems.

Goldport Capital is a Shenzhen-based asset management company.

Investment focus

Manufacturing, Medical, Biopharma
Series A, Seed, Angel
China

Portfolio highlights

REEM Healthcare — REEM Healthcare is a new type of medical device R&D and manufacturing company focused on the development and production of PHIS tiny particle units (professional, wearable, and implantable), new medical device IoT goods, and the provision of professional smart disease management services.Ruimeng Medical brings together senior experts in medicaldevices, health management, mobile Internet, big data processing, and other fields to form a new medical device R&D and production enterprise dedicated to the R&D and production of PHIS small particle units (professional, wearable, and implantable), new medical device IoT products, and professional intelligent disease management services.
Ruigu New Materials — Ruigu New Materials is a new energy battery technology developer that specializes in the research, development, and manufacture of new energy battery technology, as well as the research, development, and production of sulfide solid electrolytes.
Xingrong Technology — Xingrong Technology is an electronic component company that offers services to consumers including fabrication of electronic components.

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Angel
China, United States, Colombia

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, Singapore, United States

Portfolio highlights

Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
Feiduwei — Feiduwei specializes in researching and developing mixed digital and analog circuits, including signal chain and power-related chips.The devices are utilized in automotive electronics, industrial control, consumer electronics, and various other applications.
IKX technologies — IKX technologies specializes in designing and manufacturing INS/IML/IMR diaphragms for automotive interior and exterior decoration. With a technical route, the company ensures product performance is comparable to overseas suppliers while significantly reducing production costs. Yongmaxi's business with major OEMs is progressingsmoothly, with stable batch shipments and cooperation with first-tier OEMs on popular models.

Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.

Investment focus

Information Technology, E-Commerce, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
Arnatar Therapeutics — Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Moonshot AI — Dark Side of the Moon is an AI large-scale model company.

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, India

Portfolio highlights

Muyanzhiyu — Muyanzhiyu is a software development service provider that specializes in the creation of intelligent vehicle equipment, software development, and the production of basic artificial intelligence software.
Silicon Box — We are an advanced chiplet interconnection company specialising in cutting-edge semiconductor integration services. Learn more about our proprietary integration technology.
Global Data Solutions — Global Data Solutions designs, builds, and operates data centers in the People's Republic of China together with its subsidiaries. It provides colocation, managed hosting, and managed cloud services, as well as consulting services. Global Data Solutions's data centers service customers that primarily operate in the Internet and bankingindustries in Shanghai and Beijing municipalities; and Jiangsu, Guangdong, Sichuan, and Hebei Provinces. It serves cloud service providers, Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. William Wei Huang founded Global Data Solutions in 2000. It has its headquarters in Shanghai in the People's Republic of China.

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China

Portfolio highlights

JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
Juhe Biotechnology — Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies.

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
Decent power — Decent Power specializes in producing oil-free scroll air compressor main engines, aiming to become a leading enterprise through innovative products and operations.
ReviR Therapeutics — ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.

Investment focus

Health Care, Education, Medical
Series A, Series B, Series C
China, United States, United Kingdom

Portfolio highlights

G7 — G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).
Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Angel, Series B
China

Portfolio highlights

MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Investment focus

Manufacturing, Health Care, Medical
Series A, Series B, Angel
China, United States

Portfolio highlights

Fusionride — Fusionride offers smart mobility solutions, using sensor FUSION at the center of its perception technology. It focuses on independent research and development in smart driving technologies, including HPC hardware platforms, sensing, 4D-imaging radar, and fusion.
Hengding Materials — Hengding Materials is a manufacturer of hot isostatic pressing equipment for civilian usage. It offers cost-effective solutions for essential metal wear components in numerous industrial fields.
Aoshi Environmental — Aoshi Environmental specializes in high-performance reverse osmosis and nanofiltration membrane separation, the company offers products for various industries, including drinking water, food, and pharmaceuticals.

Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Series B
China

Portfolio highlights

Errui Xinyue — Errui Xinyue is a developer of early diagnosis technology and products for neurodegenerative diseases. It focuses on the research and use of exosome-related technologies and is committed to progressing the advancement of life and health through technological innovation.
Maybio Matrix — Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing，Shanghai and Hefei.

Investment focus

Manufacturing, Semiconductor, Health Care
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Metrono — Metrono is a manufacturer of cable and optical cable that provides high-performance rail transit special cable solutions and supplies a full range of European standard locomotive cables.
Da Instruments — Da Instruments is a technology company that specializes in satellite communications and automotive electronics test and measurement solutions.
Qingyan Haolong New Energy — Qingyan Haolong New Energy manufactures PTC heating film products that are designed for new energy lithium battery thermal management systems.

Taiyu Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Angel
China

Portfolio highlights

Immorna — Immorna specializes in the production of RNA-based therapeutics.
ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
Ai Sensing Technology — Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.
Bowang Pharmaceutical — Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.

In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support theirneeds not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
China, United States, France

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.

Tiantu Capital is a venture capital association.

Investment focus

Food and Beverage, E-Commerce, Internet
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

EVENTEC — EVENTEC is a service robot system solution provider.
Leman Biotech — Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, Hong Kong

Portfolio highlights

Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
Virtus Medical Holdings — Virtus brings together congenial health professionals from a diverse array of healthcare disciplines to provide a full range of healthcare services, from wellness and prevention to treatment and rehabilitation, for people of different ages and at different stages of the health cycle. Virtus’ priority in patient-centred care coordination can be seenthrough the implementation of an integrated medical tower, a custom clinic management system and a health consultant team.
Innostellar Biotherapeutics — Innostellar Biotherapeutics is a biopharmaceutical startup that focuses on gene therapy for novel medication research, manufacturing, and commercialization.Innostellar Biotherapeutics core team includes scientists and specialists from prestigious institutions and laboratories, as well as senior executives from leading biopharmaceutical firms.

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Seed, Angel
China, United States

Portfolio highlights

Simnova — Simnova Biotherapeutics is a biopharmaceutical company that focuses on the research and development of cell therapies for cancer treatment. The company's primary therapeutic focus is CAR-based cell therapy for patients with either hematologic malignancies or solid tumors. Simnova Biotherapeutics is known for its innovative approach todeveloping patient-centered therapeutics using current science and technology. The company's lead product is SNC102, a cell therapy product that has been approved for clinical trials. Simnova Biotherapeutics is committed to creating a healthy, inclusive, and harmonious working environment.
Xinhong life — Xinhong Life is a technologically creative medical company dedicated to developing a medical enterprise based on ultrasound energy technology as well as combining drug and device technology. Xinhong Life, which specializes in interventional ultrasound technology and combined drug-device technology, has developed a number of technology platforms,including interventional ultrasound energy technology, combined drug-device technology, software and algorithm architecture technology, and industrial transformation platforms, and continues to develop innovative energy device products that truly address clinical pain points.
Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.

Investment focus

Manufacturing, Internet, Software
Series A, Series B, Series C
China, India, United States

Portfolio highlights

Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
LTZ Therapeutics — LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Tanshao Technology — Tanshao Technology specializes in semiconductor device manufacturing equipment.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

Chemomab — Pioneering Innovative Treatments for Patients with Fibrosis-Related Diseases
MBX Biosciences — Homepage - MBX Biosciences
Brenig Therapeutics — Brenig Therapeutics develops therapies for neurodegenerative disorders.

Longpan Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Series B
China, Cayman Islands

Portfolio highlights

Yingshu Life — Yingshu Life is a research and development manufacturer of minimally invasive medical devices.
Reju Therapeutics — Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions.
Xunyao Biotechnology — Xunyao Biotech is a cutting-edge medication development company focused on coagulation and fibrosis. Xunyao Biotech specializes on the research and development of novel pharmaceuticals in the disciplines of coagulation and fibrosis.

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Seed
China, United States

Portfolio highlights

Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

Investment focus

Medical, Health Care, Medical Device
Series A, Series B, Angel
China, United States

Portfolio highlights

Filan Air — Filan Air develops technology for improving air quality, such as air treatment for medical laboratories.
Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Angel, Seed
China, United States

Portfolio highlights

Huaboron Neutron — Huaboron Neutron is a biotechnology company that develops boron drugs and boron neutron capture therapy devices for the diagnosis of malignant cancers.
Nafi Pharmaceuticals — Nafi Pharmaceuticals develops novel medications for central nervous system illnesses.
Atom Bioscience & Pharmaceutical — Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Investment focus

Health Care, Manufacturing, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
Xinshi Technology — Xinshi Technology is the developer of semiconductor front-end measurement and testing equipment.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.

Ping An Ventures is a professional VC under Ping An Insurance (Group) Company of China, Ltd. with focused interest in start-ups of emerging innovation. It is committed to growing with the partners and driving success by provision of both funds and managerial expertise, resources and a platform."

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Israel

Portfolio highlights

Xiaoqule — Xiaoqule (Happy Community) is a Chinese community-focused e-commerce platform. It is a subsidiary of Gejia.Xiaoqule helps local businesses provide cost-effective products and services to the local community. On the platform, the consumer can order food such as seasonal fruits and vegetables from local businesses. Xiaoqule connects localbusinesses with local consumers, which shortens transportation time and maintains quality of goods. Xiaoqule also serves as a logistical company, providing transportation, technology, marketing and customer support.
Zhangshang Tangyi — Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Xgene Pharmaceutical — Xgene Pharmaceutical is a pharmaceutical company.

Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.

Investment focus

Health Care, Software, Information Technology
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

HaploX Biotechnology — HaploX Biotechnology is a Shenzhen-based genetic sequencing company.
Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.

DT Capital Partners is a private equity investment firm that provides growth capital to early and expansion stage companies. They invest in dynamic businesses that have high growth potential, strong management teams, and demonstrated revenue models in both technology-based and traditional industries. DT Capital Partners currently manages overUSD$500 Million in capital across multiple US dollar and RMB funds, and also has a close affiliation with Madrone Capital in the US, the investment entity for members of the Walton family.In addition to funds, the invested company also benefits from their extensive experience in operating capital markets across the country, close relationships with local governments and companies, and synergies with other investment companies.DT Capital Partners was awarded the “Top 10 China's Best Return Venture Capital Institution” in 2016, and the founding partners of Detong Capital, Shao Jun and Tian Lixin. DT Capital Partner was founded in 2006 and is based in Shanghai, China.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Series C
China, United States, South Korea

Portfolio highlights

Sincetrue — Sincetrue is an enterprise specializing in hydrogen energy technology, offering water electrolysis, hydrogen drying, and purification solutions, with patented technologies for efficient drying and stable purification.
Worg Pharmaceuticals — Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases.
Next Generation Gene Therapeutics — Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world.NGGT was founded in March 2020by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

Investment focus

Software, Artificial Intelligence, Internet
Series A, Seed, Series B
China, United States, Singapore

Portfolio highlights

Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
Heranova Lifesciences — Hekaiwei is a provider of innovative solutions for women's health.